Literature DB >> 19860750

Postoperative impact of regular tobacco use, smoking or snuffing, a prospective multi-center study.

M Brattwall1, M Warrén Stomberg, N Rawal, M Segerdahl, E Houltz, J Jakobsson.   

Abstract

BACKGROUND: The aim was to study the effects of different tobacco administration routes on pain and post-operative nausea and vomiting (PONV), following three common day surgical procedures: cosmetic breast augmentation (CBA), inguinal hernia repair (IHR) and arthroscopic procedures (AS). We have prospectively investigated the effects of regular tobacco use in ambulatory surgery.
METHODS: The 355 allocated patients were followed during recovery and the first day at home.
RESULTS: Thirty-two percent of the patients used tobacco regularly, 33% of CBA, 27% of IHR and 34% of AS. Pain was well controlled in the post-anesthesia care unit at rest; during ambulation, 37% of all patients reported VAS>3. Tobacco use had no impact on early post-operative pain. Post-operative nausea was experienced by 30% of patients during recovery while in hospital. On day 1, 14% experienced nausea. We found a significant reduction of PONV among tobacco users (smoking and/or snuffing). Smoking or snuffing reduced the risk of PONV by nearly 50% in both genders on the day of surgery and at the first day at home. The reduction of PONV was equal, regardless of tobacco administration routes.
CONCLUSION: We found that regular use of tobacco, both by smoking and snuffing, had a significant effect on PONV during the early post-operative period. Non-tobacco users undergoing breast surgery were found to have the highest risk for PONV. We could not see any influence of nicotine use on post-operative pain. Thus, it seems of value to identify regular tobacco use, not only smoking, as a part of the pre-operative risk assessment.

Entities:  

Mesh:

Year:  2009        PMID: 19860750     DOI: 10.1111/j.1399-6576.2009.02140.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  Transcutaneous nicotine does not prevent postoperative nausea and vomiting: a randomized controlled trial.

Authors:  Christoph Czarnetzki; Eduardo Schiffer; Christopher Lysakowski; Guy Haller; Daniel Bertrand; Martin R Tramèr
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.

Authors:  Canhua Xiao; Alexandra Hanlon; Qiang Zhang; Benjamin Movsas; Kian Ang; David I Rosenthal; P Félix Nguyen-Tan; Harold Kim; Quynh Le; Deborah Watkins Bruner
Journal:  Cancer       Date:  2013-12-11       Impact factor: 6.860

3.  The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.

Authors:  Susan W Wesmiller; Richard A Henker; Susan M Sereika; Heidi S Donovan; Li Meng; Gary S Gruen; Ivan S Tarkin; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2012-06-20       Impact factor: 2.522

Review 4.  Intranasal or transdermal nicotine for the treatment of postoperative pain.

Authors:  Annette M Matthews; Rongwei Fu; Tracy Dana; Roger Chou
Journal:  Cochrane Database Syst Rev       Date:  2016-01-12

5.  Effect of preoperative smoking cessation on postoperative pain outcomes in elderly patients with high nicotine dependence.

Authors:  Shuai Zhao; Fan Chen; Dunwei Wang; Hongdan Wang; Wei Han; Yuan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.